Lymphangioma usually occurs in children and usually involves neck and axillary region. Renal or perirenal cystic lymphangioma, hepatic lymphangiomatosis and splenic lymphangiomatosis are very rare disorders. Perirenal cystic lymphangioma combined with multiple hepatic cysts or multiple splenic cysts suspected to be lymphangiomatosis has not been reported in adults in this country until now. The patient was a 43-year-old woman who had been diagnosed with multiple splenic cysts about ten years ago. She presented with a perirenal cystic lesion discovered incidentally and we detected small multiple hepatic cysts additionally with abdominal CT. We removed perirenal cyst surgically and a perirenal lymphangioma was confirmed.
Adult ; Child ; Female ; Humans ; Kidney ; Liver ; Lymphangioma ; Lymphangioma, Cystic ; Neck ; Spleen

Quadricuspid aortic valves (QAVs) is a rare congenital malformation. We report two cases of QAV associated with aortic regurgitation. The one is incidentally diagnosed and uncomplicated, and the other is symptomatic and associated with infective endocarditis. In most cases, QAVs are associated with valve regurgitation, with a concurrent stenosis in some patients, while only a small number of QAVs are functionally normal. Once the diagnosis has been made, echocardiographic follow-up is recommended, because of progression to severe valve regurgitation and the risk of infective endocarditis.
Aortic Valve Insufficiency* ; Aortic Valve* ; Constriction, Pathologic ; Diagnosis ; Echocardiography ; Endocarditis* ; Humans

BACKGROUND AND OBJECTIVES: Several studies have shown that angiotensin II receptor blockers (ARBs) improve endothelial function and arterial stiffness. Telmisartan is a highly selective ARB that activates peroxisome proliferator-activated receptor gamma (PPARgamma). The purpose of this study was to evaluate the effects of telmisartan, such as endothelial function, arterial stiffness, and insulin sensitivity, in patients with essential hypertension. SUBJECTS AND METHODS: Thirty-nine patients with essential hypertension were administered telmisartan (80 mg once daily) using an open-labeled and prospective protocol. The patients were examined before and 8 weeks after treatment to assess changes in flow mediated-vasodilation (FMD), pulse wave velocity (PWV), quantitative insulin-sensitivity check index (QUICKI), homeostasis model assessment (HOMA), and adiponection. RESULTS: The systolic and diastolic blood pressure (BP) decreased from 153+/-15 mmHg and 90+/-13 mmHg to 137+/-16 mmHg and 84+/-10 mmHg after telmisartan treatment, respectively (p<0.01). Telmisartan therapy increased the FMD from 7.6+/-3.5 to 9.0+/-2.8% (p<0.01). The following parameters of arterial stiffness were significantly improved after telmisartan therapy: brachial-ankle pulse wave velocity (baPWV), from 17.2+/-3.1 to 15.9+/-2.6 m/sec; heart-carotid PWV (hcPWV), from 9.7+/-1.8 to 9.0+/-1.9 m/sec; and heart-femoral PWV (hfPWV), from 11.3+/-1.9 to 10.7+/-1.9 m/sec (p<0.01). There were no changes in QUICKI, the HOMA level, and plasma adiponectin (p=NS). CONCLUSION:These results suggest that telmisartan is effective in improving endothelial function and arterial stiffness in patients with essential hypertension.
Adiponectin ; Angiotensin II Type 1 Receptor Blockers ; Angiotensin Receptor Antagonists ; Arteriosclerosis ; Benzimidazoles ; Benzoates ; Blood Pressure ; Endothelium, Vascular ; Homeostasis ; Humans ; Hypertension ; Insulin Resistance ; Plasma ; PPAR gamma ; Prospective Studies ; Pulse Wave Analysis ; Vascular Stiffness

No abstract available.
Aged ; Cardiovascular Agents/therapeutic use ; Echocardiography ; Electrocardiography ; Female ; Humans ; Stress, Psychological/*complications ; Tachycardia, Ventricular/diagnosis/drug therapy/*etiology ; Takotsubo Cardiomyopathy/diagnosis/drug therapy/*etiology ; Treatment Outcome

BACKGROUND/AIMS: Cardiovascular (CV) disease is the leading cause of death in patients with chronic kidney disease. It may be related to nontraditional risk factors such as arterial stiffness (AS) and vascular calcification (VC). AS, as evaluated by pulse wave velocity (PWV), has been established to be an independent predictor of CV mortality. This study investigated the relationship between AS and VC, and contributing risk factors in patients with hypertension undergoing hemodialysis (HD). METHODS: Cross-sectional data are reported on 65 patients with hypertension and 61 patients undergoing HD. PWV, abdominal computed tomography (CT) scans, and serum markers of mineral metabolism were measured. RESULTS: Mean heart-femoral (hf) PWV and brachial-ankle (ba) PWV were higher in the HD group than in the hypertensive group. In a univariate linear regression analysis, hfPWV was positively correlated with age (r = 0.613, p < 0.01), pulse pressure (r = 0.540, p < 0.01), highest aortic VC (HU) (r = 0.483, p < 0.01), gender (r = 0.354, p < 0.05), and diabetes (r = 0.331, p < 0.05). Aortic VC was also positively correlated with pulse pressure (r = 0.483, p < 0.01), age (r = 0.392, p < 0.01), and dialysis duration (r = 0.389, p < 0.05). In a multivariate regression analysis, old age, diabetes, male gender, high pulse pressure, and dialysis duration were significantly associated with PWV in that order, whereas high pulse pressure, dialysis duration, and age were significant factors for aortic VC. Arterial stiffness was more prevalent and advanced in the diabetic HD group than that in the nondiabetic HD group. CONCLUSIONS: A high prevalence of arterial stiffness was noted in patients undergoing HD, which was closely related with old age, diabetes, male gender, and high pulse pressure. Patients with diabetes undergoing HD may be at risk for vascular stiffness.
Arteriosclerosis ; Biomarkers ; Blood Pressure ; Cause of Death ; Cross-Sectional Studies ; Dialysis ; Humans ; Hypertension ; Linear Models ; Male ; Prevalence ; Pulse Wave Analysis ; Renal Dialysis ; Renal Insufficiency, Chronic ; Risk Factors ; Vascular Calcification ; Vascular Stiffness

BACKGROUND: TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin), a material of agent orange, was reported as a deadly poison in spite of its presence at extremely small doses. It has been reported that TCDD can cause various kinds of cancers and harmful effects on humans. However, a correlation between exposure to TCDD and cardiovascular disease is not yet known. Thus, we intended to examine the correlation between TCDD exposure and cardiovascular disease through an analysis of coronary angiograms in veterans of the Vietnam War. METHODS: A consecutive 115 patients undergoing coronary angiograms between April 2004 and June 2005 at Gwangju Veterans Hospital were analyzed. The patients were divided into two groups: 57 patients exposed to TCDD (Group I, average age 59.2+/-4.2 years) and 58 patients that were not exposed to TCDD (Group II, Average age 60.1+/-5.6 years). The clinical and coronary angiographic findings were evaluated. RESULTS: Baseline clinical characteristics, inflammatory markers and echocardiographic parameters were not different between patients in the two groups. The incidence of diabetes (43.9% vs. 25.0%, p=0.035) and hyperlipidemia (47.4% vs. 27.6%, p=0.028) were higher in group I patients than group II patients. Significant coronary artery stenosis was more common in group I (45 cases, 78.9%) thanin group II (33 cases, 56.9%) (p=0.011). CONCLUSIONS: There was a higher incidence of diabetes, hyperlipidemia, and significant coronary artery stenosis in patients that underwent a diagnostic coronary angiogram that were previously exposed to TCDD.
Angioplasty ; Cardiovascular Diseases* ; Citrus sinensis* ; Coronary Disease ; Coronary Stenosis ; Echocardiography ; Gwangju ; Hospitals, Veterans ; Humans ; Hyperlipidemias ; Incidence ; Tetrachlorodibenzodioxin ; Veterans* ; Vietnam*

A case of a 52-year-old man with retroperitoneal fibrosis and a horseshoe kidney is presented. Horseshoe kidney is one of the most common renal anomalies and complicated with urinary tract infection, hydronephrosis, calculi, tumor of the renal pelvis, and other multiple congenital abnormalities. Idiopathic retroperitoneal fibrosis is a rare disease characterized by the presence of a retroperitoneal tissue, consisting of chronic inflammation and marked fibrosis, which often entraps ureters or other abdominal organs. The correlation between horseshoe kidney and retroperitoneal fibrosis has not been described. We report a rare case of idiopathic retroperitoneal fibrosis with horseshoe kidney disease demonstrating good response to steroid therapy.
Calculi ; Congenital Abnormalities ; Fibrosis ; Humans ; Hydronephrosis ; Inflammation ; Kidney ; Kidney Diseases ; Kidney Pelvis ; Middle Aged ; Rare Diseases ; Retroperitoneal Fibrosis ; Steroids ; Ureter ; Urinary Tract Infections

BACKGROUND/AIMS: Steroid therapy is reported to improve the clinical outcome of IgA nephropathy. In addition, recent studies have revealed that deflazacort has fewer side effects than prednisolone. This study examined the effect of steroids and compared the clinical efficacy of deflazacort and prednisolone in patients with IgA nephropathy. METHODS: We retrospectively reviewed 136 patients with biopsy-proven IgA nephropathy who received deflazacort (n=50), prednisolone (n=29), or neither (n=59), and in whom blood pressure was controlled with angiotensin converting enzyme inhibitors or angiotensin receptor blockers. The mean duration of steroid administration was 9.5+/-9.1 months. The initial clinical status and change in the amount of protein in the 24-hour urine were compared among the three groups. RESULTS: The baseline characteristics (age, blood pressure, serum creatinine level, initial protein in the 24-hour urine, and creatinine clearance) did not differ significantly among the groups. The decrement of protein in the 24-hour urine was higher in the deflazacort and prednisolone groups, as compared with the control group (4.4+/-5.4, 4.2+/-1.5, and 2.1+/-3.1 g/day, respectively, p=0.013). The increment in the creatinine clearance was higher in the deflazacort and prednisolone groups, as compared with the control group (11.5+/-16.4, 12.3+/-26.2, and 4.8+/-14.91.3+/-0.9, respectively, p=0.009). There were no significant differences in the above parameters between the deflazacort and prednisolone groups. CONCLUSIONS: Steroid therapy reduces urinary protein excretion in IgA nephropathy, and the clinical efficacy of deflazacort and prednisolone was found to be similar.
Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors ; Blood Pressure ; Creatinine ; Glomerulonephritis ; Glomerulonephritis, IGA ; Humans ; Immunoglobulin A ; Prednisolone ; Pregnenediones ; Proteinuria ; Retrospective Studies ; Steroids